Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
LOUISVILLE, Ky., March 02, 2026 (GLOBE NEWSWIRE) -- TurnPoint Services, the industry leader in applied technology, growth, diversified service lines, and profitability for residential HVAC,...
-
TORONTO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- OMERS, the defined benefit pension plan for Ontario’s broader municipal sector employees, earned a 2025 investment return of 6%, or $8.2 billion, net of...
-
Tiverton, Ontario, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Driven by cutting-edge, innovative tooling and thousands of hours of safe, dedicated effort from its workforce and Ontario’s skilled trades,...
-
Kincardine, Ontario, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The Ontario Chamber of Commerce (OCC) independent economic impact analysis final report confirms a proposed new large-scale Bruce C nuclear...
-
$32.5 million in revenue, including $31.3 million in neffy U.S. net product revenue in third quarter of 2025 Continued U.S. product growth driven by direct-to-consumer (DTC) investments and...
-
Aclaris Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Third quarter total revenue of $160 million, Crysvita® revenue of $112 million and Dojolvi® revenue of $24 million Reaffirm 2025 Revenue Guidance: Total revenue between $640 million to $670 million,...
-
Bolsters balance sheet with non-dilutive capital at an attractive cost Beginning in January 2028 OMERS will receive an additional 25% of the North American Crysvita® royalty interest capped at 1.55...
-
Xanadu Produced the First Networked, Modular and Scalable Quantum Computer with their Aurora System in Early 20251First Pure Play Quantum Computing Company to Achieve Quantum Supremacy with their...
-
– Transaction valued at $250 million, with up to $14 million in future milestones – – BioCryst will focus on driving ORLADEYO sales in the U.S. while Neopharmed Gentili will lead commercialization...